SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-001519
Filing Date
2019-05-14
Accepted
2019-05-14 17:16:25
Documents
46
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q phio_10q.htm 10-Q 261918
2 EMPLOYMENT AGREEMENT phio_ex1001.htm EX-10.1 75864
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER phio_ex3101.htm EX-31.1 7697
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER phio_ex3201.htm EX-32.1 5165
  Complete submission text file 0001683168-19-001519.txt   1789940

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE phio-20190331.xml EX-101.INS 211886
6 XBRL SCHEMA FILE phio-20190331.xsd EX-101.SCH 19567
7 XBRL CALCULATION FILE phio-20190331_cal.xml EX-101.CAL 34635
8 XBRL DEFINITION FILE phio-20190331_def.xml EX-101.DEF 83718
9 XBRL LABEL FILE phio-20190331_lab.xml EX-101.LAB 184666
10 XBRL PRESENTATION FILE phio-20190331_pre.xml EX-101.PRE 151916
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36304 | Film No.: 19823870
SIC: 2834 Pharmaceutical Preparations